Establishment of a Sleep and Sleep-disorder Research Cohort in Patients With Neurological Disorders

Jilin University

Status: Invitation-only

Conditions: Neurology; Sleep

Treatments: Other: Symptomatic and Etiological Treatment

Study type: Observational

Funder types: Other

Identifiers

NCT07374393

SD-V01

Details and patient eligibility

About

This study aims to establish a research cohort on sleep and sleep disorders in patients with neurological diseases to systematically evaluate the relationship between various neurological conditions and sleep characteristics or disturbances.

Full description

The cohort will include patients with confirmed diagnoses such as stroke, Parkinson's disease, epilepsy, cognitive disorders, neuroinfections, and immune-mediated neurological diseases, with collection of demographic data, medical history, and lifestyle factors. All participants will undergo standardized polysomnography (PSG), sleep questionnaires, assessments of cognition, mood, daytime function, as well as relevant imaging and laboratory tests. Designed as a prospective observational study, the cohort will focus on sleep architecture alterations, periodic limb movements, sleep-disordered breathing, REM sleep behavior disorder, nocturnal awakenings, heart rate, and oxygen saturation, and their associations with disease severity and progression. The data will provide a basis for exploring the mechanisms, early indicators, and potential interventions for sleep disturbances in neurological patients.

Enrollment: 100 estimated patients

Sex: All

Ages: 14 to 80 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Confirmed diagnosis of neurological diseases, including but not limited to: Stroke (ischemic or hemorrhagic)，Parkinson's disease and other movement disorders，Epilepsy，Cognitive disorders (mild cognitive impairment or dementia)，Neuroinfections or immune-mediated neurological disorders
• Ability to complete standardized polysomnography, sleep questionnaires, and assessments of cognition, mood, and daytime function
• Voluntary participation and provision of written informed consent

Exclusion criteria

• Severe psychiatric disorders or unstable mental status precluding study assessments，Recent (within 3 months) serious infection, surgery, or major medical event
• Previously diagnosed severe primary sleep disorders (e.g., sleep apnea) under active treatment， -Pregnancy or lactation (if the study involves medication or interventions)

Trial design

100 participants in 1 patient group

patients with neurological diseases

Description:

patients with confirmed diagnoses such as stroke, Parkinson's disease, epilepsy, cognitive disorders, neuroinfections, and immune-mediated neurological diseases

Treatment:

Other: Symptomatic and Etiological Treatment